Sjögren’s Syndrome News

The American College of Rheumatology “strongly recommends” against the use of glucocorticoids as a first-line therapy for interstitial lung disease in patients with systemic sclerosis-associated ILD, according to newly released guidelines.

Following last year’s U.S. Supreme Court’s decision overturning federal abortion protections, rheumatologists must change their practice with regard managing patients’ reproductive health, said presenter at the 2023 AWIR annual conference.

Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, offered a breakdown of the June issue, which is led by a cover story on pediatric rheumatology workforce shortage concerns.

Pregnancies among patients with Sjögren’s syndrome demonstrate “very good prognoses” for both the parent and fetus, and do not reflect an increased risk for adverse outcomes, according to data published in The Lancet Rheumatology.

There are several differences in the symptoms reported among male and female patients with primary Sjögren’s syndrome, according to data published in the Journal of Clinical Rheumatology.

EULAR has initiated a survey that will collect data directly from patients on the impact and outcomes of rheumatic and musculoskeletal diseases, according to a statement released during the EULAR 2023 Congress.

Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit.

DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjӧgren’s syndrome, according to a speaker at the 2023 Congress of Clinical Rheumatology meeting.

DESTIN, Fla. — Stratifying Sjögren’s disease patients by symptoms or biologic parameters may help rheumatologists hit therapeutic targets, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.